Clinical Trial Update: Normal Binding of R-[11C]PK11195 in Human Subjects [Phase 1]

View source ↗

Summary

This Phase 1 update reports on the binding behavior of the radioligand R-[11C]PK11195 in human subjects in a study on normal aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Aging

Drugs mentioned

• R-[11C]PK11195 (PK11195)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Normal Aging | Phase 1 | Status: UNKNOWN